Tillotts Pharma UK Ltd was established in March 2010 and is the largest wholly owned affiliate of Switzerland based Tillotts Pharma AG, part of the Japanese Zeria Group. Jeremy Thorpe (Managing Director) joined in July 2012, with a clear focus on optimising the portfolio of gastrointestinal (GI) health products. Tillotts Pharma UK is now market leader in the UK oral mesalazine market. Passionate about GI Health: With over 30 years’ expertise in developing and manufacturing treatments for inflammatory bowel disease (IBD), we understand the disease, the market and the challenges GI healthcare professionals and patients face. Tillotts Pharma UK strive to be the preferred partner in GI health and are committed to supporting the NHS to improve outcomes for patients. Tillotts are motivated by the aim to consistently deliver quality and value to the NHS and are dedicated to improving the lives of people with GI disease and supporting those who care for them. Working at Tillotts: At Tillotts, we are dedicated to advancing our employees’ skills and supporting them with their professional development. We encourage individuals’ involvement in all aspects of the business in which they are interested, to gain a deeper insight into the full picture. Working at Tillotts, we can provide you with: • A competitive salary • A good work/life balance • A variety of recognition programmes • Sociable and friendly working environment • Insurance package Tillotts Values: At Tillotts, we are committed to honest and ethical business conduct in all of our activities, consistent with all applicable laws and the highest professional standards. We focus on realising the following values: • Passion • Performance • Progress • Accountability • Collaboration • Integrity © Tillotts Pharma UK: All rights reserved. NU-01021 - February 2021